JP3939821B2 - O / W / O type emulsion - Google Patents
O / W / O type emulsion Download PDFInfo
- Publication number
- JP3939821B2 JP3939821B2 JP22085497A JP22085497A JP3939821B2 JP 3939821 B2 JP3939821 B2 JP 3939821B2 JP 22085497 A JP22085497 A JP 22085497A JP 22085497 A JP22085497 A JP 22085497A JP 3939821 B2 JP3939821 B2 JP 3939821B2
- Authority
- JP
- Japan
- Prior art keywords
- oil
- type emulsion
- emulsion
- type
- component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000839 emulsion Substances 0.000 title claims description 77
- 239000004094 surface-active agent Substances 0.000 claims description 24
- 239000004530 micro-emulsion Substances 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000002537 cosmetic Substances 0.000 claims description 5
- 239000002245 particle Substances 0.000 claims description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 4
- 238000010008 shearing Methods 0.000 claims description 4
- 235000011187 glycerol Nutrition 0.000 claims description 2
- 239000003921 oil Substances 0.000 description 30
- 235000019198 oils Nutrition 0.000 description 30
- 238000004519 manufacturing process Methods 0.000 description 17
- -1 polyoxyethylene Polymers 0.000 description 15
- 239000012071 phase Substances 0.000 description 13
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 10
- 239000008346 aqueous phase Substances 0.000 description 8
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 8
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 235000019441 ethanol Nutrition 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 4
- 229960003237 betaine Drugs 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 229920001296 polysiloxane Polymers 0.000 description 4
- 229940031439 squalene Drugs 0.000 description 4
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 4
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 238000004945 emulsification Methods 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 3
- 229940032094 squalane Drugs 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 239000010495 camellia oil Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000010419 fine particle Substances 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000008385 outer phase Substances 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- NRWMBHYHFFGEEC-KTKRTIGZSA-N (9Z)-1-O-octadec-9-enyl glycerol Chemical compound CCCCCCCC\C=C/CCCCCCCCOCC(O)CO NRWMBHYHFFGEEC-KTKRTIGZSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical compound C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 description 1
- NKJOXAZJBOMXID-UHFFFAOYSA-N 1,1'-Oxybisoctane Chemical compound CCCCCCCCOCCCCCCCC NKJOXAZJBOMXID-UHFFFAOYSA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- SJMBETQHZHCXGR-UHFFFAOYSA-N 1-(2-octoxyethoxy)octane Chemical compound CCCCCCCCOCCOCCCCCCCC SJMBETQHZHCXGR-UHFFFAOYSA-N 0.000 description 1
- IFBDFMPSOCGRKA-UHFFFAOYSA-N 1-octadecoxyoctadecane;phosphoric acid Chemical compound OP(O)(O)=O.CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC IFBDFMPSOCGRKA-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- MXVBVDSNBADJOC-UHFFFAOYSA-N 2-(4,5-dihydroimidazol-1-yl)-4-hydroxybutanoic acid;sodium Chemical compound [Na].OCCC(C(O)=O)N1CCN=C1 MXVBVDSNBADJOC-UHFFFAOYSA-N 0.000 description 1
- XPALGXXLALUMLE-UHFFFAOYSA-N 2-(dimethylamino)tetradecanoic acid Chemical compound CCCCCCCCCCCCC(N(C)C)C(O)=O XPALGXXLALUMLE-UHFFFAOYSA-N 0.000 description 1
- LNCJHVLXANMHHD-UHFFFAOYSA-N 2-[2-heptadecyl-1-(2-hydroxyethyl)-4,5-dihydroimidazol-1-ium-1-yl]acetate Chemical compound CCCCCCCCCCCCCCCCCC1=NCC[N+]1(CCO)CC([O-])=O LNCJHVLXANMHHD-UHFFFAOYSA-N 0.000 description 1
- WBIQQQGBSDOWNP-UHFFFAOYSA-N 2-dodecylbenzenesulfonic acid Chemical compound CCCCCCCCCCCCC1=CC=CC=C1S(O)(=O)=O WBIQQQGBSDOWNP-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- BKTMEKOLXCZRFW-UHFFFAOYSA-N 3-(octadecylamino)propanoic acid Chemical compound CCCCCCCCCCCCCCCCCCNCCC(O)=O BKTMEKOLXCZRFW-UHFFFAOYSA-N 0.000 description 1
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 1
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical class NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 240000002834 Paulownia tomentosa Species 0.000 description 1
- 235000010678 Paulownia tomentosa Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 235000006732 Torreya nucifera Nutrition 0.000 description 1
- 244000111306 Torreya nucifera Species 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 150000004996 alkyl benzenes Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 150000008366 benzophenones Chemical class 0.000 description 1
- 229940000635 beta-alanine Drugs 0.000 description 1
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-aminopropionic acid Natural products NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- SAOKZLXYCUGLFA-UHFFFAOYSA-N bis(2-ethylhexyl) adipate Chemical compound CCCCC(CC)COC(=O)CCCCC(=O)OCC(CC)CCCC SAOKZLXYCUGLFA-UHFFFAOYSA-N 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- VJHINFRRDQUWOJ-UHFFFAOYSA-N dioctyl sebacate Chemical compound CCCCC(CC)COC(=O)CCCCCCCCC(=O)OCC(CC)CCCC VJHINFRRDQUWOJ-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- DDXLVDQZPFLQMZ-UHFFFAOYSA-M dodecyl(trimethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCC[N+](C)(C)C DDXLVDQZPFLQMZ-UHFFFAOYSA-M 0.000 description 1
- 229940060296 dodecylbenzenesulfonic acid Drugs 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 238000000635 electron micrograph Methods 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 229940093476 ethylene glycol Drugs 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- DWMMZQMXUWUJME-UHFFFAOYSA-N hexadecyl octanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC DWMMZQMXUWUJME-UHFFFAOYSA-N 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- BARWIPMJPCRCTP-UHFFFAOYSA-N oleic acid oleyl ester Natural products CCCCCCCCC=CCCCCCCCCOC(=O)CCCCCCCC=CCCCCCCCC BARWIPMJPCRCTP-UHFFFAOYSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 229940056211 paraffin Drugs 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- ONQDVAFWWYYXHM-UHFFFAOYSA-M potassium lauryl sulfate Chemical compound [K+].CCCCCCCCCCCCOS([O-])(=O)=O ONQDVAFWWYYXHM-UHFFFAOYSA-M 0.000 description 1
- 229940116985 potassium lauryl sulfate Drugs 0.000 description 1
- MQOCIYICOGDBSG-UHFFFAOYSA-M potassium;hexadecanoate Chemical compound [K+].CCCCCCCCCCCCCCCC([O-])=O MQOCIYICOGDBSG-UHFFFAOYSA-M 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 229960004063 propylene glycol Drugs 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- BTURAGWYSMTVOW-UHFFFAOYSA-M sodium dodecanoate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 description 1
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 229940082004 sodium laurate Drugs 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- YYGNTYWPHWGJRM-AAJYLUCBSA-N squalene group Chemical group CC(C)=CCC\C(\C)=C\CC\C(\C)=C\CC\C=C(/C)\CC\C=C(/C)\CCC=C(C)C YYGNTYWPHWGJRM-AAJYLUCBSA-N 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 229940117986 sulfobetaine Drugs 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229940104261 taurate Drugs 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 150000003625 trehaloses Chemical class 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 229910052724 xenon Inorganic materials 0.000 description 1
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Images
Landscapes
- Cosmetics (AREA)
- Colloid Chemistry (AREA)
Description
【0001】
【発明の属する技術分野】
本発明は、O/W/O型エマルションに関し、詳しくは親水性界面活性剤の含有量が少ないにもかかわらず、水相成分を多量に含有でき、きわめて安定なO/W/O型エマルションに関する。
【0002】
【従来の技術】
従来より、化粧料や皮膚外用剤において、乳化型のクリームや乳液が多用されている。このような乳化の形態には大別してW/OエマルションタイプとO/Wエマルションタイプがあるが、W/O型エマルションは外相が油相なので、皮膚に塗布した際の保護実感の高いクリームや乳液が得られるが、反面塗布時の伸びが悪いという欠点を有している。近年ではシリコーン系油剤やシリコーン系界面活性剤を配合することで塗布時の伸びの悪さを軽減できるようになったが、O/W型エマルションに比べるとまだ十分に改善されたとはいえない状況である。逆にO/W型エマルションは外相が水相であるため、塗布時のクリームや乳液の伸びは良好であるものの、塗布後の皮膚の保護効果や保湿効果が今一つ高くないという欠点を有する。
【0003】
このような両者の特性を生かす方法としてO/W/O型エマルションの形態とすることが提案されている。このようなO/W/O型エマルションの製法としては、第1段階でO/W型エマルションを作成し、ついで第2段階としてこのO/W型エマルションを油相に分散する方法が一般的に用いられている。しかしながら、第1段階のO/W型エマルションの平均粒子径は、一般に知られている乳化方法では1μm程度が限界であるため、このO/W型エマルションを油相に分散して得られるO/W/O型エマルションの平均粒子径はさらに大きくなってしまい、温度的、経時的に不安定なものとなりやすい。そのため、相当大量の界面活性剤を配合して第1段階のO/W型エマルションを微粒子化する必要があるが、こうした場合には目的とする微粒子のO/W/O型エマルションが製造できたにしても製造に使用した界面活性剤の量が多いため、界面活性剤と他の相との相互作用が強く働き、やはり不安定なエマルションになってしまうという問題があった。
【0004】
また、従来のO/W/O型エマルションを得る方法では、さっぱり感を出すために水相の含有量を多くするには、エマルションのサイズを小さくすることにより水相の含有量を増やす方法が考えられる。しかしこのためには従来の技術では親水性界面活性剤の量を増やす必要があり、前述のO/W/O型エマルションの安定性の悪化の問題のほかに、界面活性剤の量が多くなるため、塗布時の感触が悪化し、せっかく水相量を増やして塗布時のさっぱり感を出そうとしてもキャンセルされてしまい、結局はさっぱり感のあるO/W/O型エマルションを提供することが難しいものであった。
【0005】
【発明が解決しようとする課題】
すなわち、本発明は40重量%以上の大量の水相を含有することができる上、きわめて安定なO/W/O型エマルションを提供することを目的とする。
【0006】
【課題を解決するための手段】
本発明者等はこの点について、鋭意研究を進めた結果、400気圧以上の高圧ホモジナイザー処理に相当する剪断力を与えることによって得られるO/W型マイクロエマルションでは親水性界面活性剤がごく少量でも0.1μm以下のマイクロエマルションを製造でき、これをさらに油相中に分散してやれば、温度的、経時的にきわめて安定なO/W/O型複合エマルションが得られること、またこのO/W/O型エマルションには水相を40重量%以上の量で含有させることができるため、従来にないさっぱりした感触のエマルションが得られることを見い出し、本発明を完成させるに至った。
【0007】
すなわち、本発明はごく少量の親水性界面活性剤で水相を多量に含有でき、しかも経時的、温度的に安定なO/W/O型エマルションに関するものである。
【0008】
【発明の実施の形態】
以下、本発明について詳細に説明する。
【0009】
本発明において第1段階のO/W型エマルションの製造に用いられるA成分の親水性界面活性剤としては、O/W型のマイクロエマルションを得るために、HLBが親水性のものを用いる必要があるが、それ以外は通常の親水性界面活性剤を用いることができ、特に限定はされない。
具体的に例を挙げると、陰イオン界面活性剤としては、例えば、ラウリン酸ナトリウム、パルミチン酸カリウム等の脂肪酸セッケン、ラウリル硫酸ナトリウム、ラウリル硫酸カリウム等の高級アルキル硫酸エステル塩、ポリオキシエチレン(以下、POEという)ラウリル硫酸トリリエタノールアミン等のアルキルエーテル硫酸エステル塩、ラウロイルザルコシンナトリウム等のN−アシルサルコシン酸、N−ミリストイル−N−メチルタウリンナトリウム等の高級脂肪酸アミドスルホン酸塩、POEオレイルエーテルリン酸ナトリウム、POEステアリルエーテルリン酸等のリン酸エステル塩、ジ−2−エチルヘキシルスルホコハク酸ナトリウム等のスルホコハク酸塩、ドデシルベンゼンスルホン酸ナトリウム、ドデシルベンゼンスルホン酸トリエタノールアミン、ドデシルベンゼンスルホン酸等のアルキルベンゼンスルホン酸塩、N−ラウロイルグルタミン酸モノナトリウム、N−ステアロイルグルタミン酸ジナトリウム、N−ミリストイル−L−グルタミン酸モノナトリウム等のN−アシルグルタミン酸塩等があげられる。
陽イオン界面活性剤としては、例えば、塩化ステアリルトリメチルアンモニウム、塩化ラウリルトリメチルアンモニウム等のアルキルトリメチルアンモニウム塩、ジアルキルジメチルアンモニウム塩、アルキル四級化アンモニウム塩、アルキルアミン塩等が挙げられる。
【0010】
両性界面活性剤としては、例えば、2−ウンデシル−N,N-(ヒドロキシエチルカルボキシメチル)−2−イミダゾリンナトリウム、2−ココイル−2−イミダゾリニウムヒドロキサイド−1−カルボキシエチロキシ2ナトリウム塩等のイミダゾリン系両面界面活性剤、2−ヘプタデシル−N−カルボキシメチル−N−ヒドロキシエチルイミダゾリニウムベタイン、ラウリルジメチルアミノ酢酸ベタイン、アルキルベタイン、アミドベタイン、スルホベタイン等のベタイン系界面活性剤、N−ラウリルβ−アラニン、N−ステアリルβ−アラニン等のアミノ酸塩等が挙げられる。
【0011】
これら親水性界面活性剤は1種または2種以上を組合せて用いることができる。
本発明での第1段階として製造されるO/W型マイクロエマルションに用いられるB成分の油分は、通常化粧料に用いられる油分であれば特には限定されず、具体的な例としては、例えば流動パラフィン、スクワラン、スクワレン、プリスタン、パラフィン、ワセリン等の炭化水素類等、ジオクチルエーテル等のエーテル類等、エチレングリコールジオクチルエーテル等のジエーテル類等、オクタン酸セチル、ミリスチン酸オクチルドデシル、パルミチン酸イソプロピル、ステアリン酸ブチル、ミリスチン酸ミリスチル、オレイン酸デシル、オレイン酸オレイル等のモノエステル類、イソステアリルアルコール、オクチルドデカノール等の高級アルコール類等、オレイルアルコールやラノリンアルコール等の不飽和高級アルコール類等、エイコセン酸等の高級脂肪酸類、セバシン酸ジ−2−エチルヘキシル、アジピン酸ジ−2−エチルヘキシル等のジエステル類等、グリセロールモノオレイルエーテル等のグリセリルモノエーテル類、ラウロイルラウリルアミン等の酸アミド類等、アボガド油、ツバキ油、タートル油、マカデミアナッツ油、トウモロコシ油、ミンク油、オリーブ油、ナタネ油、卵黄油、ゴマ油、パーシック油、小麦胚芽油、サザンカ油、ヒマシ油、アマニ油、サフラワー油、綿実油、エノ油、大豆油、落花生油、茶実油、カヤ油、コメヌカ油、シナギリ油、日本キリ油、ホホバ油、胚芽油、カカオ脂、ヤシ油等の植物、動物油脂類等が挙げられる。これらの油分のなかでも、流動パラフィンや、スクワランのような炭化水素系油分のごとき極性の低い油分を用いると、得られるO/W/O型エマルションがさらに安定化するので特に好ましい。本発明ではこれら油分の一種または二種以上を用いるものである。
【0012】
本発明における第1段階で製造されるO/W型マイクロエマルションは、親水性界面活性剤が最終的に得られるO/W/O型エマルションの全量に対して0.01〜1重量%、好ましくは0.01〜0.5重量%の配合量となる量を用いて製造される。最終的に得られるO/W/Oエマルション全量に対して1重量%を越える量の親水性界面活性剤を配合してO/W型マイクロエマルションを製造した場合は、かかるO/W型マイクロエマルションを油相に分散してO/W/O型エマルションを製造した場合には、O/W型エマルションのままでO/W/O型エマルションにならないか、なったとしてもエマルション中の親水性界面活性剤が他相に影響を与え、得られたエマルションの温度的、経時的安定性がきわめて悪化してしまう。0.01重量%〜0.5重量%の範囲であればより安定に製造でき、特に好ましい。
【0013】
このような親水性活性剤の配合量が少量であるO/W型マイクロエマルションは、A成分の親水性界面活性剤とB成分の油分とC成分の水とを、強力な剪断力を与えうる乳化機、例えば高圧ホモジナイザー、あるいは超音波乳化機等を用いて調整が可能である。高圧ホモジナイザーを用いる場合には、400気圧以上の圧力下で乳化するのが好ましいが、さらに好ましくは、50℃以上の温度と600気圧以上の圧力下で乳化するのが良い。このようにして得られたO/W型マイクロエマルションの平均粒子径は0.01〜0.2μmの範囲にあることが好ましい。
【0014】
本発明に用いられるO/W型マイクロエマルションには、前記親水性界面活性剤、油分、水の他に、任意成分として化粧料に一般に使用される各種の成分を配合することができる。
例えばエチルアルコール、プロピルアルコール、イソプロピルアルコール等の低級アルコール類、エチレングリコール、プロピレングリコール、1,3−ブチレングリコール、グリセリン、ジグリセリン、ジエチレングリコール、ジプロピレングリコール、ポリエチレングリコール等の多価アルコール類、ソルビタン、ソルビトール、マルチトール、マルトトリオース、マンニトール等の糖類、ヒアルロン酸ナトリウム、トレハロース、硫酸化トレハロース等の多糖類やその誘導体、アスコルビン酸、アスコルビン酸燐酸エステル、トコフェロール、酢酸トコフェロール、ビタミンA等のビタミン類、パラベン類やグルコン酸クロルヘキシジン等の防腐剤類、ブチルヒドロキシトルエン等の酸化防止剤、アラビアゴム、カルボキシビニルポリマー等の増粘剤、クエン酸塩、酢酸塩等のpH調整剤、パラアミノ安息香酸誘導体、ベンゾフェノン誘導体等の紫外線吸収剤、酸化チタン、シリカゲル、タルク等の粉体類、香料、色素等、ヒアルロン酸、胎盤抽出物、朝鮮人参エキス、ステロール配糖体、β−カロチン、スーパーオキシドデスムターゼ等の各種目的に応じた薬効成分等を任意に選択して用いることができる。
また、本発明の効果を損なわない範囲で、A成分の親水性界面活性剤の他に、親油性界面活性剤を少量併用することも可能である。
【0015】
本発明ではこのO/W型マイクロエマルションを、さらに油相に分散させてO/W/O型エマルションを製造する。ここでの分散は通常の剪断力を与え得る乳化機、例えばディスパー等で十分である。O/W型マイクロエマルションを分散させる油相の成分としては、通常化粧料に使用される油分であれば特に限定はされず、例えばO/W型マイクロエマルションで例示した油分や、揮発性シリコーン油、ポリジメチルシロキサン、有機変性ポリシロキサン等を使用することができる。この油相にはこの他、シリコーン系界面活性剤や蔗糖脂肪酸エステル等の親油性界面活性剤を適量配合してやると良好に複合エマルションを製造できるのでさらに好ましい。
【0016】
以下、製造例及び実施例をもって本発明を説明する。
<O/W型マイクロエマルション>
表1〜3の成分を用いて本発明に適用される製造例1〜3のO/W型エマルションを製造した。
【0017】
【製造例1】
【0018】
【表1】
【0019】
【製造例2】
【0020】
【表2】
【0021】
【製造例3】
【0022】
【表3】
【0023】
製造例1〜3とも、A成分とB成分をマイクロフルイダイザー(みづほ工業製)を用いてO/W型マイクロエマルションとした。得られたマイクロエマルションの平均粒子径は光学顕微鏡で観察したところ、製造例1では70mμ、製造例2では150mμ、製造例3では100mμであった。
【0024】
<本発明のO/W/O型エマルションの実施例>
製造例1〜3のO/W型エマルションを用いて、表4〜6の組成のO/W/O型エマルションを製造した。
【0025】
【実施例1】
【0026】
【表4】
【0027】
A成分とB成分をディスパーで混合し、5000rpmで撹拌してO/W/O型エマルションを得た。
【0028】
【実施例2】
【0029】
【表5】
【0030】
A成分とB成分をディスパーで混合し、5000rpmで撹拌してO/W/O型エマルションを得た。
【0031】
【実施例3】
【0032】
【表6】
【0033】
A成分とB成分をディスパーで混合し、5000rpmで撹拌してO/W/O型エマルションを得た。
【0034】
得られた実施例1のO/W/O型エマルションの電子顕微鏡写真を図1に示す。
【0035】
【図1】
【0036】
<O/W/O型エマルションの安定性試験>
次に実施例1のO/W/O型エマルションと、通常のディスパーを用いて製造した製造例1と同一組成のO/W型マイクロエマルションを用いて製造したO/W/O型エマルションを比較例1、O/W型マイクロエマルションの脂肪酸と水酸化カリウムの量を10倍に増量(増量分は水で調整)してマイクロフルイダイザーで乳化して得られたO/W/O型エマルションを比較例2として、これらの経時安定性を比較した。結果を表7に示す。
【0037】
【表7】
【0038】
表7の結果に明らかなように、本発明のO/W/O型エマルションは非常に安定であった。
【0039】
<O/W/O型エマルションの使用テスト>
実施例3のO/W/O型エマルションに対して、製造例3のマイクロエマルションの代わりに純水を用いて製造したW/O型エマルションを比較例3とし、女性専門パネラー10名による使用感触の官能評価を実施した。評価項目は塗布時ののびの軽さと塗布後の保護感の2項目とし、それぞれ5段階で評価をつけてもらい、10人の平均値で評価した。得られた結果を表8に示す。
【0040】
【表8】
【0041】
表8の結果から、本発明のO/W/O型エマルションは、W/O型エマルションに比べてきわめてのびが軽いにもかかわらず、塗布後の保護感はW/O型エマルションと同等以上であることが証明された。
【0042】
また、本発明の実施例1のO/W/O型エマルション中のスクワランをスクワレンに全量置換したO/W/O型エマルションを製造し、別途同量のスクワレンを含有するO/W型エマルションを製造し、それぞれを40℃の温度条件でキセノンテスターで12時間処理してTBA法により、過酸化物の生成率を調べた。その結果、本発明のO/W/O型エマルションでは最内相に不飽和化合物であるスクワレンが存在するため、TBA値は3と低かったが、O/W型エマルションではTBA値が53まで上昇していた。この結果、本発明のO/W/O型エマルションでは不飽和化合物のような酸素に対する安定性の低い物質をきわめて安定に配合しうることが判明した。
【0043】
【発明の効果】
本発明のO/W/O型エマルションは親水性界面活性剤の含有量が少ないにもかかわらず、水相成分を多量に含有でき、きわめて安定なO/W/O型エマルションを製造することができる。その結果、きわめてのびが軽く、W/O型エマルションに匹敵する塗布後の保護感を与えるエマルションを提供することが可能となった。また、本発明のO/W/O型エマルションは最内相に酸素に不安定な物質を安定に配合することが可能である。
【0044】
【図面の簡単な説明】
実施例1のO/W/O型エマルションを凍結割断後、走査型電子顕微鏡で撮影した写真である。[0001]
BACKGROUND OF THE INVENTION
The present invention relates to an O / W / O type emulsion, and more particularly to an extremely stable O / W / O type emulsion that can contain a large amount of an aqueous phase component even though the content of a hydrophilic surfactant is small. .
[0002]
[Prior art]
Conventionally, emulsified creams and emulsions are frequently used in cosmetics and external preparations for skin. Such emulsification forms can be broadly classified into W / O emulsion type and O / W emulsion type. Since the outer phase of the W / O emulsion is an oil phase, creams and emulsions with a high degree of protection when applied to the skin. However, there is a disadvantage that the elongation at the time of coating is poor. In recent years, it has become possible to reduce the poor elongation at the time of application by blending a silicone-based oil agent or a silicone-based surfactant, but it has not been sufficiently improved compared to O / W emulsions. is there. On the other hand, since the outer phase is an aqueous phase, the O / W type emulsion has a drawback that although the elongation of the cream or the emulsion at the time of application is good, the protective effect and moisturizing effect of the skin after application are not so high.
[0003]
As a method of making use of both of these characteristics, it has been proposed to form an O / W / O type emulsion. As a method for producing such an O / W / O type emulsion, there is generally a method in which an O / W type emulsion is prepared in the first stage and then this O / W type emulsion is dispersed in the oil phase as the second stage. It is used. However, the average particle size of the first stage O / W type emulsion is limited to about 1 μm by a generally known emulsification method, and therefore, the O / W type emulsion obtained by dispersing this O / W type emulsion in the oil phase. The average particle size of the W / O type emulsion is further increased and is likely to be unstable over time and with time. For this reason, it is necessary to add a considerable amount of a surfactant to make the first stage O / W emulsion into fine particles. In such a case, the desired fine particle O / W / O type emulsion could be produced. However, since the amount of the surfactant used in the production is large, the interaction between the surfactant and the other phase works strongly, and there is a problem that the emulsion is still unstable.
[0004]
Moreover, in the conventional method of obtaining an O / W / O type emulsion, in order to increase the content of the aqueous phase in order to give a refreshing feeling, there is a method of increasing the content of the aqueous phase by reducing the size of the emulsion. Conceivable. However, for this purpose, it is necessary to increase the amount of the hydrophilic surfactant in the conventional technique. In addition to the above-described problem of deterioration of the stability of the O / W / O emulsion, the amount of the surfactant is increased. Therefore, the touch at the time of application deteriorates, and even if the amount of water phase is increased to give a refreshing feeling at the time of application, it is canceled, and eventually an O / W / O type emulsion with a refreshing feeling is provided. It was difficult.
[0005]
[Problems to be solved by the invention]
That is, an object of the present invention is to provide an extremely stable O / W / O type emulsion that can contain a large amount of an aqueous phase of 40% by weight or more.
[0006]
[Means for Solving the Problems]
As a result of diligent research on this point, the inventors of the present invention have obtained even a very small amount of hydrophilic surfactant in the O / W type microemulsion obtained by applying a shearing force corresponding to a high-pressure homogenizer treatment of 400 atm or higher. A microemulsion having a size of 0.1 μm or less can be produced, and if this is further dispersed in an oil phase, an O / W / O type composite emulsion that is extremely stable with temperature and time can be obtained. Since the aqueous phase can be contained in the O-type emulsion in an amount of 40% by weight or more, it has been found that an emulsion with a refreshing feel that has never been obtained can be obtained, and the present invention has been completed.
[0007]
That is, the present invention relates to an O / W / O emulsion that can contain a large amount of an aqueous phase with a very small amount of a hydrophilic surfactant and that is stable over time and temperature.
[0008]
DETAILED DESCRIPTION OF THE INVENTION
Hereinafter, the present invention will be described in detail.
[0009]
In the present invention, as the A-component hydrophilic surfactant used for the production of the first stage O / W type emulsion, it is necessary to use a hydrophilic HLB in order to obtain an O / W type microemulsion. However, other than that, a normal hydrophilic surfactant can be used and is not particularly limited.
Specific examples include anionic surfactants such as fatty acid soaps such as sodium laurate and potassium palmitate, higher alkyl sulfates such as sodium lauryl sulfate and potassium lauryl sulfate, and polyoxyethylene (hereinafter referred to as “anionic surfactant”). Alkyl ether sulfates such as trilaurethanolamine lauryl sulfate, N-acyl sarcosine acids such as sodium lauroyl sarcosine, higher fatty acid amide sulfonates such as sodium N-myristoyl-N-methyl taurate, POE oleyl ether Phosphate ester salts such as sodium phosphate and POE stearyl ether phosphoric acid, sulfosuccinate such as sodium di-2-ethylhexyl sulfosuccinate, sodium dodecylbenzenesulfonate, dodecylbenzenesulfone Triethanolamine, alkyl benzene sulfonates, such as dodecylbenzene sulfonic acid, N- lauroyl glutamate monosodium, N- stearoyl glutamate disodium, N- acyl glutamates such as N- myristoyl -L- monosodium glutamate and the like.
Examples of the cationic surfactant include alkyltrimethylammonium salts such as stearyltrimethylammonium chloride and lauryltrimethylammonium chloride, dialkyldimethylammonium salts, alkyl quaternized ammonium salts, and alkylamine salts.
[0010]
Examples of amphoteric surfactants include 2-undecyl-N, N- (hydroxyethylcarboxymethyl) -2-imidazoline sodium, 2-cocoyl-2-imidazolinium hydroxide-1-carboxyethyloxy disodium salt, and the like. Imidazoline-based double-sided surfactant, 2-heptadecyl-N-carboxymethyl-N-hydroxyethylimidazolinium betaine, lauryldimethylaminoacetic acid betaine, alkylbetaine, amide betaine, sulfobetaine and other betaine surfactants, N- Examples thereof include amino acid salts such as lauryl β-alanine and N-stearyl β-alanine.
[0011]
These hydrophilic surfactants can be used alone or in combination of two or more.
The oil component B used in the O / W type microemulsion produced as the first step in the present invention is not particularly limited as long as it is an oil component usually used in cosmetics. Liquid paraffin, squalane, squalene, pristane, hydrocarbons such as paraffin, petrolatum, etc., ethers such as dioctyl ether, diethers such as ethylene glycol dioctyl ether, cetyl octanoate, octyldodecyl myristate, isopropyl palmitate, Monoesters such as butyl stearate, myristyl myristate, decyl oleate and oleyl oleate, higher alcohols such as isostearyl alcohol and octyldodecanol, unsaturated higher alcohols such as oleyl alcohol and lanolin alcohol, etc. Higher fatty acids such as seric acid, diesters such as di-2-ethylhexyl sebacate, di-2-ethylhexyl adipate, glyceryl monoethers such as glycerol monooleyl ether, acid amides such as lauroyl lauryl amine, etc. Avocado oil, camellia oil, turtle oil, macadamia nut oil, corn oil, mink oil, olive oil, rapeseed oil, egg yolk oil, sesame oil, persic oil, wheat germ oil, sasanqua oil, castor oil, flaxseed oil, safflower oil, cottonseed oil, Examples include eno oil, soybean oil, peanut oil, tea seed oil, kaya oil, rice bran oil, cinnagiri oil, Japanese kiri oil, jojoba oil, germ oil, cocoa butter, coconut oil, and animal oils. Among these oils, it is particularly preferable to use a low polarity oil such as liquid paraffin or a hydrocarbon oil such as squalane because the resulting O / W / O emulsion is further stabilized. In the present invention, one or more of these oils are used.
[0012]
The O / W type microemulsion produced in the first step in the present invention is preferably 0.01 to 1% by weight, preferably based on the total amount of the O / W / O type emulsion from which the hydrophilic surfactant is finally obtained. Is produced using an amount of 0.01 to 0.5% by weight. When an O / W type microemulsion is prepared by blending a hydrophilic surfactant in an amount exceeding 1% by weight with respect to the total amount of the finally obtained O / W / O emulsion, such an O / W type microemulsion is produced. When an O / W / O type emulsion is produced by dispersing the oil in the oil phase, the O / W type emulsion remains as an O / W / O type emulsion or the hydrophilic interface in the emulsion. The active agent affects the other phases, and the temperature stability and temporal stability of the obtained emulsion are extremely deteriorated. A range of 0.01% by weight to 0.5% by weight can be more stably produced, and is particularly preferable.
[0013]
Such an O / W type microemulsion containing a small amount of the hydrophilic active agent can give a strong shearing force to the hydrophilic component A component, the oil component B and the water C component. Adjustment can be performed using an emulsifier such as a high-pressure homogenizer or an ultrasonic emulsifier. In the case of using a high-pressure homogenizer, it is preferable to emulsify under a pressure of 400 atm or higher, more preferably emulsification at a temperature of 50 ° C. or higher and a pressure of 600 atm or higher. The average particle size of O / W microemulsion obtained in this manner is preferably in the range of 0.01~0.2μ m.
[0014]
In the O / W type microemulsion used in the present invention, various components generally used in cosmetics can be blended as optional components in addition to the hydrophilic surfactant, oil and water.
For example, lower alcohols such as ethyl alcohol, propyl alcohol, and isopropyl alcohol, polyhydric alcohols such as ethylene glycol, propylene glycol, 1,3-butylene glycol, glycerin, diglycerin, diethylene glycol, dipropylene glycol, and polyethylene glycol, sorbitan, Saccharides such as sorbitol, maltitol, maltotriose, mannitol, polysaccharides such as sodium hyaluronate, trehalose, sulfated trehalose and derivatives thereof, vitamins such as ascorbic acid, ascorbic acid phosphate ester, tocopherol, tocopherol acetate, vitamin A , Preservatives such as parabens and chlorhexidine gluconate, antioxidants such as butylhydroxytoluene, gum arabic, carboxyvinyl poly -Thickeners such as-, pH adjusters such as citrate and acetate, UV absorbers such as paraaminobenzoic acid derivatives and benzophenone derivatives, powders such as titanium oxide, silica gel and talc, fragrances, dyes, etc. Medicinal components such as acid, placenta extract, ginseng extract, sterol glycoside, β-carotene, superoxide desmutase and the like can be arbitrarily selected and used.
Further, a small amount of a lipophilic surfactant can be used in combination with the component A hydrophilic surfactant as long as the effects of the present invention are not impaired.
[0015]
In the present invention, this O / W type microemulsion is further dispersed in an oil phase to produce an O / W / O type emulsion. For the dispersion here, an emulsifier capable of giving a normal shearing force, such as a disper, is sufficient. The component of the oil phase in which the O / W type microemulsion is dispersed is not particularly limited as long as it is an oil component usually used in cosmetics. For example, the oil component exemplified in the O / W type microemulsion and volatile silicone oil Polydimethylsiloxane, organically modified polysiloxane, and the like can be used. In addition to this, it is more preferable to add an appropriate amount of a lipophilic surfactant such as a silicone-based surfactant or a sucrose fatty acid ester to the oil phase because a composite emulsion can be produced satisfactorily.
[0016]
Hereinafter, the present invention will be described with reference to production examples and examples.
<O / W type microemulsion>
O / W type emulsions of Production Examples 1 to 3 applied to the present invention were produced using the components shown in Tables 1 to 3.
[0017]
[Production Example 1]
[0018]
[Table 1]
[0019]
[Production Example 2]
[0020]
[Table 2]
[0021]
[Production Example 3]
[0022]
[Table 3]
[0023]
In each of Production Examples 1 to 3, the A component and the B component were converted into O / W type microemulsions using a microfluidizer (manufactured by Mizuho Kogyo). The average particle size of the obtained microemulsion was observed with an optical microscope, in Production Example 1 70 m mu, in Production Example 2 0.99 m mu, were in Production Example 3 100 m mu.
[0024]
<Example of O / W / O emulsion of the present invention>
Using the O / W type emulsions of Production Examples 1 to 3, O / W / O type emulsions having the compositions shown in Tables 4 to 6 were produced.
[0025]
[Example 1]
[0026]
[Table 4]
[0027]
A component and B component were mixed with a disper and stirred at 5000 rpm to obtain an O / W / O type emulsion.
[0028]
[Example 2]
[0029]
[Table 5]
[0030]
A component and B component were mixed with a disper and stirred at 5000 rpm to obtain an O / W / O type emulsion.
[0031]
[Example 3]
[0032]
[Table 6]
[0033]
A component and B component were mixed with a disper and stirred at 5000 rpm to obtain an O / W / O type emulsion.
[0034]
An electron micrograph of the obtained O / W / O emulsion of Example 1 is shown in FIG.
[0035]
[Figure 1]
[0036]
<Stability test of O / W / O type emulsion>
Next, the O / W / O type emulsion of Example 1 was compared with the O / W / O type emulsion produced using an O / W type microemulsion having the same composition as in Production Example 1 produced using a normal disper. Example 1 O / W / O type emulsion obtained by increasing the amount of fatty acid and potassium hydroxide of O / W type microemulsion 10 times (adjusted with water) and emulsifying with microfluidizer As Comparative Example 2, the stability over time was compared. The results are shown in Table 7.
[0037]
[Table 7]
[0038]
As is apparent from the results in Table 7, the O / W / O emulsion of the present invention was very stable.
[0039]
<Use test of O / W / O type emulsion>
In comparison with the O / W / O type emulsion of Example 3, a W / O type emulsion produced using pure water instead of the microemulsion of Production Example 3 is referred to as Comparative Example 3, and the feeling of use by 10 female panelists is provided. The sensory evaluation of was carried out. The evaluation items were two items of lightness at the time of application and a feeling of protection after application, and each was evaluated in five stages, and the average value of 10 people was evaluated. Table 8 shows the obtained results.
[0040]
[Table 8]
[0041]
From the results of Table 8, the O / W / O type emulsion of the present invention has a protection feeling after application that is equal to or higher than that of the W / O type emulsion although it is extremely light compared to the W / O type emulsion. Proven to be.
[0042]
In addition, an O / W / O type emulsion in which all the squalane in the O / W / O type emulsion of Example 1 of the present invention was replaced with squalene was produced, and an O / W type emulsion containing the same amount of squalene was separately prepared. Each was produced, treated with a xenon tester for 12 hours at a temperature of 40 ° C., and the peroxide production rate was examined by the TBA method. As a result, in the O / W / O type emulsion of the present invention, the squalene which is an unsaturated compound is present in the innermost phase, so the TBA value was as low as 3, but in the O / W type emulsion, the TBA value increased to 53. Was. As a result, it was found that the O / W / O type emulsion of the present invention can very stably contain a substance having low stability to oxygen such as an unsaturated compound.
[0043]
【The invention's effect】
The O / W / O type emulsion of the present invention can contain a large amount of an aqueous phase component despite the low content of the hydrophilic surfactant, and can produce an extremely stable O / W / O type emulsion. it can. As a result, it has become possible to provide an emulsion that is extremely light and gives a feeling of protection after application comparable to a W / O emulsion. In addition, the O / W / O type emulsion of the present invention can stably mix an oxygen unstable substance in the innermost phase.
[0044]
[Brief description of the drawings]
It is the photograph image | photographed with the scanning electron microscope after freeze-breaking the O / W / O type | mold emulsion of Example 1. FIG.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP22085497A JP3939821B2 (en) | 1997-08-01 | 1997-08-01 | O / W / O type emulsion |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP22085497A JP3939821B2 (en) | 1997-08-01 | 1997-08-01 | O / W / O type emulsion |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH1149638A JPH1149638A (en) | 1999-02-23 |
JP3939821B2 true JP3939821B2 (en) | 2007-07-04 |
Family
ID=16757589
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP22085497A Expired - Fee Related JP3939821B2 (en) | 1997-08-01 | 1997-08-01 | O / W / O type emulsion |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3939821B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US12115238B2 (en) | 2018-11-08 | 2024-10-15 | Amorepacific Corporation | Cosmetic composition in multiple emulsion formulation |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100425259B1 (en) * | 2001-02-15 | 2004-03-30 | 한국콜마 주식회사 | Water in silicone(W/S) emulsion and its manufacturing method using line typed ultra mill |
JP7150761B2 (en) * | 2017-06-29 | 2022-10-11 | 株式会社 資生堂 | makeup cosmetics |
-
1997
- 1997-08-01 JP JP22085497A patent/JP3939821B2/en not_active Expired - Fee Related
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US12115238B2 (en) | 2018-11-08 | 2024-10-15 | Amorepacific Corporation | Cosmetic composition in multiple emulsion formulation |
Also Published As
Publication number | Publication date |
---|---|
JPH1149638A (en) | 1999-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4397286B2 (en) | Oil-in-water emulsified cosmetic and method for producing the same | |
US20020146375A1 (en) | Cosmetic or pharmaceutical lecithin-containing gels or low viscosity lecithin-containing O/W microemulsions | |
EP0930866B1 (en) | Cosmetic or dermatological microemulsion based gels | |
JPH04193814A (en) | Transparent or semitransparent cosmetic | |
US7153516B2 (en) | Ringing nanogel compositions | |
JP2008100937A (en) | O/w type finely emulsified preparation for external use and method for producing the same | |
JP2006327952A (en) | Oil in water type emulsion composition and method for producing the same | |
JP3335151B2 (en) | Microemulsion | |
JP3614511B2 (en) | Oil-in-water emulsified cosmetic for sunscreen | |
JP3662513B2 (en) | Emulsified cosmetics | |
JP6900002B2 (en) | Liquid crystal mixed crystal emulsified composition, liquid crystal emulsified cosmetic, liquid crystal mixed crystal emulsified composition manufacturing method and liquid crystal emulsified cosmetic manufacturing method | |
JP2017114781A (en) | Oil-in-water type emulsion composition | |
JP3939821B2 (en) | O / W / O type emulsion | |
JPS63126542A (en) | Microemulsion | |
CN118717552A (en) | Particles for emulsification, emulsified preparation, cosmetic composition and skin external preparation composition containing the same | |
US8557263B1 (en) | Cosmetic composition in the form of an oil-in-water emulsion | |
JP2006290762A (en) | Oil-in-water emulsified composition | |
CN100435773C (en) | Oil-in-water-type emulsified cosmetic preparation and process for producing the same | |
EP4327802A1 (en) | Cosmetic | |
CN110868990B (en) | Cosmetic preparation | |
JP2013049635A (en) | Liquid crystal structure for moisturizing skin, and skin care composition | |
JP3626892B2 (en) | Cosmetics | |
JP2009137909A (en) | Astringent cosmetic | |
JP2003095845A (en) | Translucent liquid cosmetic | |
JP4275872B2 (en) | Mixing topical skin composition for use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20040106 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20070329 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130406 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20160406 Year of fee payment: 9 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |